Bravo Osuna, IreneAndrés Guerrero, VanesaMolina Martínez, Irene TeresaHerrero Vanrell, María Del RocíoDe la Rosa, EnriqueCotter, Thomas2024-01-192024-01-192018Bravo-Osuna I., Andrés-Guerrero V., Molina-Martínez I.T., Herrero-Vanrell R. CHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve (2019) RSC Drug Discovery Series, 2019-January (66), pp. 164 - 178. DOI: 10.1039/9781788013666-00164. EDITORS: de la Rosa E.J., Cotter T.G. UBLISHER: Royal Society of Chemistry. ISSN: 20413203.978-1-78262-949-8978-1-78801-366-6978-1-78801-536-310.1039/9781788013666-00164https://hdl.handle.net/20.500.14352/94041Título: RSC DRUG DISCOVERY SERIES ISSN relacionados: 2041-3211 País: United Kingdom Ámbito: CIENCIAS MÉDICAS Y DE LA SALUD Campo académico: FARMACOLOGÍA Y FARMACIA Indizada en: Scopus (ELSEVIER), EMBASE (ELSEVIER) Métricas en: SJR. SCImago Journal & Country Rank, Scopus SourcesDiseases affecting the retina and the optic nerve are the major causes of irreversible blindness in the elderly population. Succesful therapy of these pathologies requires frequent administration of the active molecule close to the retinal target site. Intraocular drug delivery systems (IDDS) are emerging therapeutic tools in the treatment of diseases affecting the posterior segment, as they are able to provide effective concentrations of the drug for a long period, thus avoiding successive injections. Depending on their size, IDDS are classified in implants, microsystems and nanosystems. This chapter covers a general description of the IDDS useful for the treatment of diseases affecting retinal structures. © The Royal Society of Chemistry 2019.engCHAPTER 10: Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve.book parthttps://doi.org/10.1039/9781788013666https://books.rsc.org/books/edited-volume/702/Therapies-for-Retinal-Degeneration-Targetingmetadata only accessDrug delivery systemIntraocular drug administrationMicrotechnologyNanotechnologyOptic nerveNeurodegenerative diseasePharmaceutical technologyOphthalmologyCiencias BiomédicasTecnología farmaceúticaOftalmologíaFarmacia24 Ciencias de la Vida